hCNT1(0.1 mM inhibitor, 1 μM[3H]Thymidine) | hCNT2(0.1 mM inhibitor, 0.5 μM[3H]Inosine) | hENT1(2.0 mM inhibitor, 10 μM[3H]Uridine) | |||||
---|---|---|---|---|---|---|---|
n | Inhibitor | Activity | Prediction | Activity | Prediction | Activity | Prediction |
1 | 1-Methyladenosine | 59.5 | 63.7 | 82 | 66.3 | 36.5 | 34.9 |
2 | 2′,3′-Dideoxyadenosine | N/M | N/M | N/M | N/M | 87.6 | 86.8 |
3 | 2′,3′-Dideoxycytidine | 122.1 | 121.2 | N/M | N/M | 132 | 133.1 |
4 | 2′,3′-Dideoxyuridine | 113.6 | 117.0 | 98.7 | 113.5 | 118.3 | 115.8 |
5 | 2-Chloro-2′-deoxyadenosine (Cladribine) | 35.7 | 37.9 | 100.7 | 70.8 | 14.8 | 17.7 |
6 | 2-Chloroadenosine | 50.8 | 52.9 | 88.9 | 76.2 | 16.4 | 15.2 |
7 | 2′-Deoxyadenosine | N/M | N/M | N/M | N/M | 22.7 | 21.8 |
8 | 2′-Deoxyuridine | 28.4 | 28.2 | 36.6 | N/P | 23.3 | 27.7 |
9 | 2-Fluoro-AF-adenine (Fludarabine) | 74.5 | N/P | 104.2 | 90.6 | N/M | N/M |
10 | 3′-Deoxyadenosine | N/M | N/M | N/M | N/M | 54.6 | 55.5 |
11 | 3-Deazauridine | 63.9 | 69.7 | 101.9 | N/P | 97.4 | 95.7 |
12 | 3′-Deoxyuridine | 110.7 | 108.9 | 105.8 | 108.3 | 60 | 60.0 |
13 | 3-Methyluridine | 52.3 | 38.5 | 53.1 | 47.4 | 33.3 | 33.6 |
14 | 4-Thiouridine | 17.8 | 25.0 | 19.6 | 28.0 | 31.8 | 30.1 |
15 | 5-Bromouridine | 17.6 | 23.0 | 64 | 65.2 | N/M | N/M |
16 | 5-(2-Bromovinyl)-2′-deoxyuridine (Brivudin) | 16.2 | 11.5 | 89.1 | 105.6 | N/M | N/M |
17 | 5′-Deoxyadenosine | 73.5 | N/P | 95.9 | 93.9 | 29.8 | 31.7 |
18 | 5′-Deoxythymidine | 54 | 57.0 | N/M | N/M | 32.9 | 29.4 |
19 | 5-Fluoro-2′-deoxyuridine (Floxuridine) | 28.1 | 26.3 | 73.5 | 95.7 | 23.6 | 25.2 |
20 | 5-Fluoro-5′-deoxyuridine | 65.4 | 58.7 | 110.1 | 99.1 | N/M | N/M |
21 | 5-Fluorouridine | 28.5 | 37.2 | 31.2 | 23.0 | 29.1 | 28.0 |
22 | 5-Iodo-2′-deoxyuridine (Idoxuridine) | 16 | 19.1 | 104.4 | 109.6 | 39.9 | 39.3 |
23 | 5-Iodouridine | 16.1 | 7.4 | 101 | N/P | 20.4 | 20.7 |
24 | 5-(Trifluoromethyl)-2′-deoxyuridine (Trifluridin) | 27.1 | 23.8 | 103.4 | 114.0 | 69.8 | 69.5 |
25 | 6-Azauridine | 99.1 | 82.0 | 73.2 | 59.0 | 88.8 | N/P |
26 | 7-Deazaadenosine | 42 | 41.5 | 61.6 | 56.9 | 15.1 | 16.6 |
27 | 8-Bromoadenosine | 104.1 | 98.5 | 95.8 | 105.4 | 20.7 | 19.0 |
28 | Adenosine | 38.2 | 40.1 | 8.6 | 38.5 | 24.9 | 25.2 |
29 | Acadesine | N/M | N/M | 73 | 77.6 | 58.1 | 59.1 |
30 | AF-adenine (Vidarabine) | 89.3 | 91.4 | 99.7 | 85.8 | 32.7 | 34.6 |
31 | AF-cytosine (Cytarabine) | 131.4 | 134.7 | N/M | N/M | 49.7 | 48.5 |
32 | Cytidine | 33.6 | 28.7 | N/M | N/M | 38.2 | 35.5 |
33 | 2′,3′-Dideoxyinosine | N/M | N/M | 95.7 | 87.6 | 126.6 | 125.7 |
34 | Guanosine | N/M | N/M | 18.2 | 26.7 | 35.9 | 35.4 |
35 | Inosine | N/M | N/M | 7.6 | 34.7 | 27.3 | 30.3 |
36 | Lamivudine | 143.3 | 143.8 | N/M | N/M | 106 | 103.5 |
37 | N6,N6-Dimethyladenosine | 74.3 | N/P | 97.2 | 85.8 | 13.5 | 13.9 |
38 | N6-Methyladenosine | 47 | 52.1 | 86.9 | 81.8 | N/M | N/M |
39 | Ribavirin | N/M | N/M | 31 | 21.4 | 62.1 | 61.2 |
40 | Stavudine | 126.8 | 126.9 | N/M | N/M | 121.9 | 125.8 |
41 | Thymidine | 18.5 | 23.1 | N/M | N/M | 30 | 27.8 |
42 | Uridine | 26.2 | 32.4 | 18.3 | 23.2 | 29.8 | 30.5 |
43 | UMP | N/M | N/M | N/M | N/M | 123 | 124.1 |
44 | Zidovudine | 91.3 | 92.5 | N/M | N/M | 103 | 104.5 |
N/M, not experimentally measured; N/P, not predicted (outlier); AF, 9β-d-arabinofuranosyl.